About The Journal
The International Journal of CAR T-Cell Therapy, a peer-reviewed, open-access journal, will be published by Sunvalley Communication, the publisher of ADC Review | Journal of Antibody-drug Conjugates and Onco’Zine is set to premiere in the Summer of 2021.
The International Journal of CAR T-Cell Therapy is part of the Physician’s Weekly Oncology Network, an oncology focused online publication, digital audio (broadcast and podcast) and education platform.
The Physician’s Weekly Oncology Network offers news, opinion, conference coverage and in-depth interviews with the most highly respected and internationally recognized oncology and hematology experts and Key Opinion Leaders who weigh in on landmark and practice changing research and trending topics affecting the oncology community.
The Physician’s Weekly Oncology Network also offers physicians and other healthcare professionals accredited Continuing Medical Education (CME) activities.
Editorial Advisory Board
All our journals operate under the guidance of an editorial Advisory Board. Each of our editorial Advisory Board members provide expert advice on content, and are attracting new, authors from among academic, healthcare and industry experts, and encouraging submissions of manuscripts for peer review. Our editorial Advisory Board members are typically experts or key opinion leaders in their field.
Our editorial Advisory Board members are also involved in:
- Review all submitted manuscripts;
- Help protect the quality of the journal’s content;
- Suggest, advise and contribute on the journal’s policies and scope;
- Identify topics that are of importance to readers;
- Identify topics for and act as guest editor of special issues;
- Contribute reviews, opinions and editorials;
- Attract new authors and submissions;
- Promote the journal to their colleagues and (academic) peers;
- Recommend new editorial Advisory Board members;
- Provide feedback about the journal’s performance and the growth.
The members of our editorial Advisory Board are selected by the journal’s editor(s) and publisher. If you’re interested in joining the editorial Advisory Board of the International Journal of CAR T-Cell Therapy, click on the link.
Submit a Manuscript
Submission of manuscripts and articles for inclusion in the International Journal of CAR T-cell Therapy opens in early 2021. Click on the links for more information:
Advertising and Sponsorship
For publishing, sponsoring or advertising opportunities with International Journal of CAR T-Cell Therapy, contact our sales team, via email or click on the link.